MedTrace Logo

HBV/HCV/HIV in Belgian Prisons

NCT04366492 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3045

Last updated 2020-04-29

No results posted yet for this study

Summary

To assess the prevalence of blood-borne viral infections in prisons in Belgium, screening will be executed in several prisons in Flanders, Brussels and Wallonia to obtain a geographical representative distribution.

Upon informed consent screening will be performed using whole capillary blood (finger prick testing) with three different tests for HCV Ab, HBsAg and HIV. Screening will be performed first. While awaiting the test result (15-20min), the participant can fill out a questionnaire (together with the study nurse), concerning risk factors for HCV, HBV and HIV infection. This questionnaire is filled out directly online, and will be immediately implemented in the encoded database. The database is set-up according to the rules of good clinical practice. (Castor EDC software). The results will be filled out immediately by the prison staff in this database after it is filled out by the participant, minimizing the risk of displacement of test results.

Conditions

Interventions

OTHER

Prevalence of blood borne viral infections (HBV/HCV/HIV)

rapid finger prick test for HCV Ab, HBsAg and HIV and a questionnaire

Sponsors & Collaborators

  • University Ghent

    collaborator OTHER

  • Hasselt University

    lead OTHER

Principal Investigators

  • Geert Robaeys, MD, PhD · Hasselt University

  • Dana Busschots, drs. · Hasselt University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366492 on ClinicalTrials.gov